People Briefs: JenaValve CEO; Ortho-Clinical Changes; Baxter CFOs
This article was originally published in The Gray Sheet
Executive Summary
JenaValve Technology names David Drachman as CEO. Ortho-Clinical Diagnostics makes executive changes following split from J&J. Baxter plans a CFO switch when it completes its biopharmaceutical company spinoff next year. More people news.
You may also be interested in...
Baxter Spins Off Drug Business To Focus On Devices, Anesthesia & Nutrition Products
Kidney dialysis and biosurgery will be two major focus points for a newly refined Baxter after it spins off its biopharmaceuticals business, as planned for mid-2015.
News Briefs: Medtronic’s CoreValve Approval; J&J Dx Unit Set For Sale; Google’s Glucometer Contact Lens
Medtronic gains FDA approval for its transcather CoreValve system months earlier than predicted. The Carlyle Group makes binding offer for J&J’s Ortho-Clinical Diagnostics business. Google is developing a wireless glucometer embedded within a contact lens. More news briefs.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.